Skip to main content

Director's Messages

All Director's Messages

View previous Director's Messages by topic, keyword or by year.

September 10, 2024: A Community Plan for Advancing Translational Science to Address Unmet Public Health Needs

Joni Rutter gives an overview of the NCATS Strategic Plan for 2025–2030 and shares next steps.

August 17, 2022: New Treatments Twice as Fast

Joni Rutter highlights crimps in the translational pipeline and approaches for developing new treatments twice as fast over the next decade.

February 17, 2022: Rare Diseases Have a Home at NCATS

Joni Rutter promotes Rare Disease Day at NIH and shares two key areas of rare diseases research that need to be addressed.

January 28, 2021: Bringing urgency to the public health issue of rare diseases

NCATS is committed to raising awareness about rare diseases and identifying treatments to address this urgent public health issue. The annual Rare Disease Day at NIH event held this year on March 1, offers an opportunity to advance this mission.

Dec. 21, 2020: In response to unprecedented challenges, a breakthrough year for translational science

NCATS quickly pivoted many of its existing platforms, technologies and programs to address COVID-19 in March. The translational science approaches to COVID-19 similarly can speed solutions for many diseases and future pandemics.

May 29, 2020: Creating the data platforms needed to guide our response to COVID-19

New COVID-19 data integration projects show the power of data sharing to address a public health crisis like the COVID-19 pandemic. NCATS’ new online resources describe NCATS work that brings a translational science approach to addressing COVID-19.

January 27, 2020: The Personal and Public Health Imperative of Rare Diseases

Christopher P. Austin, M.D., shares how his encounter with an end-stage ALS patient shaped his understanding of the personal and public health benefits of translating scientific discoveries into new treatments for people with rare diseases


Last updated on August 28, 2024